Clinical Trial Update: Phase IIIb Study of APD421 in Combination as PONV Prophylaxis [Phase 3]

View source ↗

Summary

Phase IIIb study assessing APD421 in combination for postoperative nausea and vomiting prophylaxis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• APD421

Snippet

Sponsor: Acacia Pharma Ltd | Conditions: PONV | Phase 3 | Status: COMPLETED | Results posted: 2017-08-04